Lavipharm S.A. | Cash Flow
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
12,102.00
30,851.00
10,144.00
11,547.00
12,892.00
2,861
Depreciation, Depletion & Amortization
2,763.00
4,126.00
4,369.00
3,448.00
2,212.00
1,184
Other Funds
5,383.00
24,596.00
2,685.00
7,806.00
11,782.00
835
Funds from Operations
3,956.00
2,129.00
3,090.00
7,189.00
3,322.00
3,210
Changes in Working Capital
394.00
4,520.00
3,677.00
6,567.00
1,785.00
1,780
Net Operating Cash Flow
3,562.00
2,391.00
587.00
622.00
1,537.00
1,430
Capital Expenditures
130.00
1,202.00
23.00
97.00
350.00
Sale of Fixed Assets & Businesses
3,027.00
15.00
20.00
500.00
600.00
Purchase/Sale of Investments
18.00
1.00
-
-
-
Net Investing Cash Flow
2,881.00
1,161.00
104.00
418.00
250.00
Issuance/Reduction of Debt, Net
3,232.00
2,496.00
56.00
97.00
1,115.00
Net Financing Cash Flow
2,887.00
2,462.00
56.00
97.00
1,115.00
Net Change in Cash
3,964.00
1,780.00
324.00
79.00
672.00
Free Cash Flow
3,679.00
2,038.00
576.00
586.00
1,439.00
Net Assets from Acquisitions
-
-
101.00
-
-
Other Sources
2.00
27.00
-
15.00
-
Change in Capital Stock
345.00
34.00
-
-
-
Exchange Rate Effect
396.00
548.00
751.00
1,216.00
-
About Lavipharm
View Profile
